Global Injectable Drug Delivery Formulation Market Data Survey Report 2013-2025

Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.4 Scope of Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Becton, Dickinson and Company (U.S.)
  • 3.1.1 Company Information
  • 3.1.2 Product & Services
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.1.4 Recent Development
• 3.2 Baxter International Inc. (U.S.)
  • 3.2.1 Company Information
  • 3.2.2 Product & Services
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.2.4 Recent Development
• 3.3 Gerresheimer AG (Germany)
  • 3.3.1 Company Information
  • 3.3.2 Product & Services
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.3.4 Recent Development
• 3.4 Pfizer, Inc. (U.S.)
  • 3.4.1 Company Information
  • 3.4.2 Product & Services
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.4.4 Recent Development
• 3.5 Schott AG (Germany)
  • 3.5.1 Company Information
  • 3.5.2 Product & Services
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.5.4 Recent Development
• 3.6 Sandoz (Germany)
  • 3.6.1 Company Information
  • 3.6.2 Product & Services
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.6.4 Recent Development
• 3.7 Teva Pharmaceutical Industries Ltd. (Israel)
  • 3.7.1 Company Information
  • 3.7.2 Product & Services
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.8 Eli Lilly and Company (U.S.)
  • 3.8.1 Company Information
  • 3.8.2 Product & Services
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

• 4.1 Autoimmune Diseases
  • 4.1.1 Overview
  • 4.1.2 Autoimmune Diseases Market Size and Forecast
• 4.2 Hormonal Disorders
  • 4.2.1 Overview
  • 4.2.2 Hormonal Disorders Market Size and Forecast
• 4.3 Oncology
  • 4.3.1 Overview
  • 4.3.2 Oncology Market Size and Forecast
• 4.4 Orphan Diseases
  • 4.4.1 Overview
  • 4.4.2 Orphan Diseases Market Size and Forecast
• 4.5 Others
  • 4.5.1 Overview
  • 4.5.2 Others Market Size and Forecast

5 Market by Type

5.By Conventional Drug Delivery Formulations

• 5.1 Conventional Drug Delivery Formulations
  • 5.1.1 Overview
  • 5.1.2 Conventional Drug Delivery Formulations Market Size and Forecast
• 5.2 Novel Drug Delivery Formulations
  • 5.2.1 Overview
  • 5.2.2 Novel Drug Delivery Formulations Market Size and Forecast
• 5.3 Long-acting Formulations
  • 5.3.1 Overview
  • 5.3.2 Long-acting Formulations Market Size and Forecast

6 Price Overview

• 6.1 Price by Manufacturers
• 6.2 Price by Application
• 6.3 Price by Type

7 Conclusion